Accelerate COVID-19 research with SimpleStep ELISAs

Accelerate COVID-19 research with SimpleStep ELISAs

July 16, 2021

Abcam’s SimpleStep ELISA assays for key targets in COVID-19 have been extensively validated to support you in coronavirus research by ensuring quick and reproducible results.
​Fast, reproducible results are essential to all aspects of coronavirus research. Abcam’s broad range of SimpleStep ELISAs offers validated assays for key targets in COVID-19, including receptors, cytokines, cell signaling proteins, and adherence proteins.
Click here to learn more!

AFNOR Validation for SNAPduo ST Plus

AFNOR Validation for SNAPduo ST Plus

IDEXX SnapDuo ST Plus has received an AFNOR Validation.
AFNOR Certification, obtained after rigorous validation and European ring trials, confirms the exceptional performance and robustness of the SNAPduo ST Plus test:

January 29, 2021 More +
Cytokine storm in COVID-19 research

Cytokine storm in COVID-19 research

New research is rapidly accumulating around cytokine storms as a key biological response to SARS-CoV-2 infection. Get more information and learn about products associated with this process.

May 05, 2020 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us